Respuesta tumoral a la quimioterapia neoadyuvante en subtipos moleculares de cáncer de mama en Medellín, Colombia. Estudio de cohorte retrospectivo [PDF]
Revista Colombiana de Obstetricia y Ginecología, 2023 Objetivos: describir la frecuencia de la respuesta clínica y patológica, entre los diferentes subtipos moleculares de cáncer de mama, en pacientes que previamente recibieron quimioterapia neoadyuvante.
Manuela Restrepo-Mejía +4 more
doaj +2 more sources
Respuesta patológica completa de pacientes con cáncer de mama HER2 positivo tratadas con quimioterapia neoadyuvante en Colombia [PDF]
Biomédica: revista del Instituto Nacional de Salud, 2023 Introduction. Breast cancer is the most common type of cancer and the leading cause of death by cancer in women in Colombia. Approximately 15 to 20% of breast cancers overexpress HER2. Objective.
Mauricio Rodríguez +4 more
doaj +2 more sources
Cirugía Española, 2019 Resumen Introduccion La reconstruccion inmediata (RMI) tras mastectomia en pacientes que han recibido quimioterapia neoadyuvante (QTNA) sigue siendo controvertida. El objetivo de este estudio es analizar y comparar resultados oncologicos y las tasas de complicaciones y reintervencion en pacientes sometidas a QTNA y un grupo control.
Marta Allue +1 more
exaly +4 more sources
Quimioterapia neoadyuvante en cáncer de mama, localmente avanzado
Correo Científico Médico, 2013 Introducción: el cáncer de mama es actualmente el tumor maligno más frecuente en la mujer y la quimioterapia constituye una de las principales armas terapéuticas en este padecimiento. Objetivo: caracterizar el comportamiento de los enfermos con cáncer
Alexander Portelles Cruz +4 more
doaj +1 more source
Consenso de expertos basado en la evidencia: perfilamiento y manejo del carcinoma epitelial de ovario de alto grado avanzado [PDF]
Revista Colombiana de Obstetricia y GinecologíaIntroducción y objetivo: el abordaje de pacientes con cáncer epitelial de ovario (CEO) de alto grado avanzado o metastásico ha ido evolucionando a través del tiempo con el advenimiento de nuevas terapias y estrategias multimodales.
Marc E Pierre +11 more
doaj +2 more sources
Farmacia Hospitalaria, 2011 Objective: The aim of this study is to determine the hospital’s efficiency as regards neoadjuvant chemotherapy for the resection of initially unresectable metastases for patients with metastatic primary colorectal cancer and to describe the chemotherapy used. Methods: Descriptive, retrospective study of patients with colorectal cancer from 2004 to 2007.
S. Redondo Capafons +3 more
exaly +2 more sources
Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro-oesophageal cancer. [PDF]
BJS Open, 2020 Deconditioning during neoadjuvant chemotherapy is a possible parameter for predicting operative outcomes. This retrospective cohort study aimed to assess body composition changes in patients with gastro‐oesophageal cancer during neoadjuvant therapy and investigate their association with postoperative complications. Skeletal muscle index values decrease
den Boer RB +9 more
europepmc +2 more sources
Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma. [PDF]
BJS Open, 2020 The neutrophil to lymphocyte ratio, dichotomized at 2·25, was strongly associated with Mandard tumour regression grade in patients who had neoadjuvant chemotherapy for oesophageal adenocarcinoma. The systemic inflammatory response may offer a novel therapeutic target for patients at risk of poor response.
Powell AGMT +6 more
europepmc +2 more sources
Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases. [PDF]
BJS Open, 2019 This study aimed to estimate the effect of neoadjuvant FOLFOX in patients undergoing upfront resectable colorectal liver metastases. After adjustment, no significant impact of FOLFOX was detected, suggesting that upfront surgery may be acceptable in patients with limited disease.
Allard MA +16 more
europepmc +2 more sources
Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy. [PDF]
BJS Open, 2020 Following propensity adjustment for stage, age and sex, neoadjuvant therapy was not associated with survival. Tumour regression is a powerful prognostic indicator, and future research should focus on identifying patients who will derive the most benefit from neoadjuvant chemotherapy.
Powell AGMT +5 more
europepmc +2 more sources